Good practices for 89Zr radiopharmaceutical production and quality control
Abstract Background During the previous two decades, PET imaging of biopharmaceuticals radiolabeled with zirconium-89 has become a consistent tool in preclinical and clinical drug development and patient selection, primarily due to its advantageous physical properties that allow straightforward radi...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SpringerOpen
2024-05-01
|
| Seri Bilgileri: | EJNMMI Radiopharmacy and Chemistry |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s41181-024-00258-y |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|